Stock Analysis on Net
Stock Analysis on Net

Intuitive Surgical Inc. (NASDAQ:ISRG)

Analysis of Profitability Ratios
Quarterly Data

Beginner level


Profitability Ratios (Summary)

Intuitive Surgical Inc., profitability ratios (quarterly data)

Microsoft Excel LibreOffice Calc
Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Return on Sales
Gross profit margin 67.07% 69.04% 69.45% 69.45% 69.47% 69.60% 69.92% 70.07% 70.22% 70.31% 70.12% 69.75% 69.97% 70.08% 69.89% 69.42% 68.38% 67.28% 66.18%
Operating profit margin 25.86% 30.52% 30.69% 30.82% 31.10% 30.51% 32.21% 33.46% 33.56% 34.52% 33.71% 33.14% 33.79% 34.40% 34.95% 35.32% 33.99% 32.23% 31.04%
Net profit margin 26.07% 30.11% 30.80% 30.94% 29.95% 29.78% 30.29% 22.31% 23.20% 23.25% 21.09% 30.16% 28.44% 27.99% 27.21% 27.51% 26.80% 25.67% 24.69%
Return on Investment
Return on equity (ROE) 13.00% 16.30% 16.69% 16.93% 16.65% 16.33% 16.89% 12.68% 13.68% 13.97% 13.97% 18.21% 18.05% 18.88% 12.74% 13.03% 13.09% 13.22% 13.63%
Return on assets (ROA) 11.24% 14.02% 14.17% 14.39% 14.18% 13.93% 14.37% 10.88% 11.70% 11.95% 11.46% 15.99% 15.55% 16.21% 11.34% 11.69% 11.73% 11.84% 12.00%

Based on: 10-Q (filing date: 2020-07-23), 10-Q (filing date: 2020-04-17), 10-K (filing date: 2020-02-07), 10-Q (filing date: 2019-10-18), 10-Q (filing date: 2019-07-22), 10-Q (filing date: 2019-04-19), 10-K (filing date: 2019-02-04), 10-Q (filing date: 2018-10-22), 10-Q (filing date: 2018-07-20), 10-Q (filing date: 2018-04-18), 10-K (filing date: 2018-02-02), 10-Q (filing date: 2017-10-20), 10-Q (filing date: 2017-07-21), 10-Q (filing date: 2017-04-19), 10-K (filing date: 2017-02-06), 10-Q (filing date: 2016-10-19), 10-Q (filing date: 2016-07-20), 10-Q (filing date: 2016-04-19), 10-K (filing date: 2016-02-02), 10-Q (filing date: 2015-10-21), 10-Q (filing date: 2015-07-22), 10-Q (filing date: 2015-04-22).

Profitability ratio Description The company
Gross profit margin Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. Intuitive Surgical Inc.’s gross profit margin ratio deteriorated from Q4 2019 to Q1 2020 and from Q1 2020 to Q2 2020.
Operating profit margin A profitability ratio calculated as operating income divided by revenue. Intuitive Surgical Inc.’s operating profit margin ratio deteriorated from Q4 2019 to Q1 2020 and from Q1 2020 to Q2 2020.
Net profit margin An indicator of profitability, calculated as net income divided by revenue. Intuitive Surgical Inc.’s net profit margin ratio deteriorated from Q4 2019 to Q1 2020 and from Q1 2020 to Q2 2020.

Profitability ratio Description The company
ROE A profitability ratio calculated as net income divided by shareholders’ equity. Intuitive Surgical Inc.’s ROE deteriorated from Q4 2019 to Q1 2020 and from Q1 2020 to Q2 2020.
ROA A profitability ratio calculated as net income divided by total assets. Intuitive Surgical Inc.’s ROA deteriorated from Q4 2019 to Q1 2020 and from Q1 2020 to Q2 2020.

Gross Profit Margin

Intuitive Surgical Inc., gross profit margin calculation (quarterly data)

Microsoft Excel LibreOffice Calc
Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selected Financial Data (US$ in thousands)
Gross profit 502,900  738,200  896,000  785,600  759,000  669,600  735,700  642,300  632,300  593,800  633,300  566,800  527,900  466,100  527,200  487,000  470,900  405,000  458,800  395,800  386,500  336,800 
Revenue 852,100  1,099,500  1,277,700  1,128,200  1,098,900  973,700  1,046,500  920,900  909,300  847,500  892,400  806,100  756,200  674,200  756,900  682,900  670,100  594,500  676,500  589,700  586,100  532,100 
Profitability Ratio
Gross profit margin1 67.07% 69.04% 69.45% 69.45% 69.47% 69.60% 69.92% 70.07% 70.22% 70.31% 70.12% 69.75% 69.97% 70.08% 69.89% 69.42% 68.38% 67.28% 66.18%
Benchmarks
Gross Profit Margin, Competitors2
Becton, Dickinson & Co. 46.24% 47.78% 47.94% 47.42% 47.28% 45.04% 45.44% 45.60% 46.00% 49.30% 49.14% 48.86% 48.57% 48.59% 47.99% 47.66% 44.92% 45.09% 45.66% 46.34% 50.87% 50.83%
Boston Scientific Corp. 68.26% 70.41% 70.98% 71.20% 71.33% 71.12% 71.37% 71.48% 71.35% 71.78% 71.34% 71.27% 71.38% 70.86% 71.09% 70.88% 70.78% 70.99% 70.94%
Danaher Corp. 55.28% 55.85% 55.74% 55.61% 55.53% 55.71% 55.83% 56.03% 56.18% 55.80% 55.61% 55.27% 55.09% 55.36% 55.29% 54.16% 53.47% 52.86% 52.34%
Medtronic PLC 69.22% 69.62% 70.04% 70.33% 70.40% 70.25% 69.77% 69.40% 69.05% 68.67% 68.73% 68.60% 68.66% 68.85% 68.29% 66.00% 66.48% 67.07% 68.86%
Stryker Corp. 63.34% 65.15% 65.14% 64.95% 65.29% 65.47% 65.72% 65.69% 65.55% 65.58% 65.68% 66.12% 66.16% 65.87% 66.18% 66.42% 66.67% 67.01% 66.38%
Thermo Fisher Scientific Inc. 45.39% 44.30% 44.35% 44.48% 44.51% 44.60% 44.57% 44.36% 44.55% 44.68% 45.15% 45.67% 45.88% 45.90% 45.80% 45.62% 45.60% 45.51% 45.72%
UnitedHealth Group Inc. 25.95% 23.52% 23.19% 22.92% 22.89% 23.15% 23.33% 23.36% 23.33% 23.28% 22.98% 23.09% 23.12% 22.99% 23.13% 22.35% 22.20% 22.73% 23.22%

Based on: 10-Q (filing date: 2020-07-23), 10-Q (filing date: 2020-04-17), 10-K (filing date: 2020-02-07), 10-Q (filing date: 2019-10-18), 10-Q (filing date: 2019-07-22), 10-Q (filing date: 2019-04-19), 10-K (filing date: 2019-02-04), 10-Q (filing date: 2018-10-22), 10-Q (filing date: 2018-07-20), 10-Q (filing date: 2018-04-18), 10-K (filing date: 2018-02-02), 10-Q (filing date: 2017-10-20), 10-Q (filing date: 2017-07-21), 10-Q (filing date: 2017-04-19), 10-K (filing date: 2017-02-06), 10-Q (filing date: 2016-10-19), 10-Q (filing date: 2016-07-20), 10-Q (filing date: 2016-04-19), 10-K (filing date: 2016-02-02), 10-Q (filing date: 2015-10-21), 10-Q (filing date: 2015-07-22), 10-Q (filing date: 2015-04-22).

1 Q2 2020 Calculation
Gross profit margin = 100 × (Gross profitQ2 2020 + Gross profitQ1 2020 + Gross profitQ4 2019 + Gross profitQ3 2019) ÷ (RevenueQ2 2020 + RevenueQ1 2020 + RevenueQ4 2019 + RevenueQ3 2019)
= 100 × (502,900 + 738,200 + 896,000 + 785,600) ÷ (852,100 + 1,099,500 + 1,277,700 + 1,128,200) = 67.07%

2 Click competitor name to see calculations.

Profitability ratio Description The company
Gross profit margin Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. Intuitive Surgical Inc.’s gross profit margin ratio deteriorated from Q4 2019 to Q1 2020 and from Q1 2020 to Q2 2020.

Operating Profit Margin

Intuitive Surgical Inc., operating profit margin calculation (quarterly data)

Microsoft Excel LibreOffice Calc
Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selected Financial Data (US$ in thousands)
Income from operations 80,600  283,000  397,600  365,700  359,000  252,200  332,000  313,300  277,400  276,700  327,000  278,600  257,500  191,500  264,400  256,400  245,400  179,000  245,900  189,900  173,800  130,400 
Revenue 852,100  1,099,500  1,277,700  1,128,200  1,098,900  973,700  1,046,500  920,900  909,300  847,500  892,400  806,100  756,200  674,200  756,900  682,900  670,100  594,500  676,500  589,700  586,100  532,100 
Profitability Ratio
Operating profit margin1 25.86% 30.52% 30.69% 30.82% 31.10% 30.51% 32.21% 33.46% 33.56% 34.52% 33.71% 33.14% 33.79% 34.40% 34.95% 35.32% 33.99% 32.23% 31.04%
Benchmarks
Operating Profit Margin, Competitors2
Becton, Dickinson & Co. 9.23% 7.91% 10.18% 12.98% 12.37% 12.63% 9.37% 9.29% 4.69% 7.32% 12.22% 9.29% 15.17% 15.21% 11.46% 13.23% 10.22% 9.60% 10.45% 12.53% 17.60% 18.59%
Boston Scientific Corp. 6.58% 10.41% 14.14% 15.66% 16.19% 16.50% 15.33% 15.57% 15.74% 14.33% 14.20% 12.53% 12.36% 6.04% 5.33% 0.44% -7.68% -0.76% -4.37%
Danaher Corp. 17.37% 18.01% 18.25% 17.46% 17.61% 17.41% 17.11% 17.27% 17.23% 16.69% 16.48% 15.73% 15.69% 16.09% 16.29% 16.51% 16.27% 16.81% 16.87%
Medtronic PLC 20.47% 21.25% 20.51% 20.48% 20.22% 21.70% 22.20% 21.35% 20.47% 18.55% 17.94% 17.72% 18.65% 18.54% 18.35% 14.56% 15.72% 16.37% 18.59%
Stryker Corp. 15.54% 18.86% 18.23% 16.96% 17.00% 17.83% 18.65% 19.22% 19.16% 18.28% 18.40% 18.46% 18.42% 18.68% 19.13% 19.78% 19.53% 19.62% 18.71%
Thermo Fisher Scientific Inc. 17.05% 17.86% 17.99% 17.88% 18.00% 15.90% 15.53% 15.03% 14.36% 14.23% 14.19% 13.94% 13.89% 13.62% 13.40% 13.28% 13.68% 13.65% 13.77%
UnitedHealth Group Inc. 9.89% 8.12% 8.19% 8.02% 7.97% 7.88% 7.71% 7.70% 7.68% 7.67% 7.60% 7.37% 7.26% 7.11% 7.03% 6.78% 6.64% 6.87% 7.05%

Based on: 10-Q (filing date: 2020-07-23), 10-Q (filing date: 2020-04-17), 10-K (filing date: 2020-02-07), 10-Q (filing date: 2019-10-18), 10-Q (filing date: 2019-07-22), 10-Q (filing date: 2019-04-19), 10-K (filing date: 2019-02-04), 10-Q (filing date: 2018-10-22), 10-Q (filing date: 2018-07-20), 10-Q (filing date: 2018-04-18), 10-K (filing date: 2018-02-02), 10-Q (filing date: 2017-10-20), 10-Q (filing date: 2017-07-21), 10-Q (filing date: 2017-04-19), 10-K (filing date: 2017-02-06), 10-Q (filing date: 2016-10-19), 10-Q (filing date: 2016-07-20), 10-Q (filing date: 2016-04-19), 10-K (filing date: 2016-02-02), 10-Q (filing date: 2015-10-21), 10-Q (filing date: 2015-07-22), 10-Q (filing date: 2015-04-22).

1 Q2 2020 Calculation
Operating profit margin = 100 × (Income from operationsQ2 2020 + Income from operationsQ1 2020 + Income from operationsQ4 2019 + Income from operationsQ3 2019) ÷ (RevenueQ2 2020 + RevenueQ1 2020 + RevenueQ4 2019 + RevenueQ3 2019)
= 100 × (80,600 + 283,000 + 397,600 + 365,700) ÷ (852,100 + 1,099,500 + 1,277,700 + 1,128,200) = 25.86%

2 Click competitor name to see calculations.

Profitability ratio Description The company
Operating profit margin A profitability ratio calculated as operating income divided by revenue. Intuitive Surgical Inc.’s operating profit margin ratio deteriorated from Q4 2019 to Q1 2020 and from Q1 2020 to Q2 2020.

Net Profit Margin

Intuitive Surgical Inc., net profit margin calculation (quarterly data)

Microsoft Excel LibreOffice Calc
Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selected Financial Data (US$ in thousands)
Net income attributable to Intuitive Surgical, Inc. 68,000  313,500  357,700  396,800  318,300  306,500  292,500  292,500  255,300  287,600  (38,800) 297,500  221,500  179,800  204,000  211,000  184,500  136,400  190,000  167,300  134,500  97,000 
Revenue 852,100  1,099,500  1,277,700  1,128,200  1,098,900  973,700  1,046,500  920,900  909,300  847,500  892,400  806,100  756,200  674,200  756,900  682,900  670,100  594,500  676,500  589,700  586,100  532,100 
Profitability Ratio
Net profit margin1 26.07% 30.11% 30.80% 30.94% 29.95% 29.78% 30.29% 22.31% 23.20% 23.25% 21.09% 30.16% 28.44% 27.99% 27.21% 27.51% 26.80% 25.67% 24.69%
Benchmarks
Net Profit Margin, Competitors2
Becton, Dickinson & Co. 6.17% 5.25% 7.13% 5.47% 6.33% 6.13% 1.95% 5.23% 0.34% 3.28% 9.10% 6.52% 10.67% 10.54% 7.82% 9.24% 6.62% 6.13% 6.76% 8.65% 12.75% 13.56%
Boston Scientific Corp. 39.24% 39.75% 43.78% 10.49% 13.85% 18.08% 17.01% 6.93% 5.48% 1.21% 1.15% 9.55% 9.04% 5.07% 4.14% 0.99% -4.34% -0.47% -3.20%
Danaher Corp. 18.35% 18.13% 16.80% 13.01% 13.11% 12.45% 13.33% 14.07% 13.84% 13.56% 13.60% 13.36% 12.63% 13.41% 15.13% 13.72% 18.39% 17.92% 16.33%
Medtronic PLC 15.11% 14.41% 15.16% 16.10% 7.44% 10.56% 10.36% 9.44% 16.93% 13.75% 13.56% 13.51% 14.62% 12.70% 12.27% 8.52% 8.92% 11.28% 13.20%
Stryker Corp. 11.38% 14.47% 13.99% 23.55% 24.99% 25.38% 26.12% 9.31% 8.28% 8.00% 8.20% 14.67% 14.22% 14.33% 14.54% 15.24% 15.33% 16.07% 14.47%
Thermo Fisher Scientific Inc. 14.12% 14.31% 14.47% 14.24% 14.24% 12.89% 12.06% 10.75% 10.36% 10.24% 10.64% 11.74% 11.80% 11.58% 11.06% 11.10% 11.35% 11.49% 11.64%
UnitedHealth Group Inc. 6.94% 5.63% 5.76% 5.61% 5.55% 5.49% 5.33% 5.75% 5.58% 5.43% 5.28% 4.41% 4.23% 4.03% 3.81% 3.64% 3.52% 3.64% 3.72%

Based on: 10-Q (filing date: 2020-07-23), 10-Q (filing date: 2020-04-17), 10-K (filing date: 2020-02-07), 10-Q (filing date: 2019-10-18), 10-Q (filing date: 2019-07-22), 10-Q (filing date: 2019-04-19), 10-K (filing date: 2019-02-04), 10-Q (filing date: 2018-10-22), 10-Q (filing date: 2018-07-20), 10-Q (filing date: 2018-04-18), 10-K (filing date: 2018-02-02), 10-Q (filing date: 2017-10-20), 10-Q (filing date: 2017-07-21), 10-Q (filing date: 2017-04-19), 10-K (filing date: 2017-02-06), 10-Q (filing date: 2016-10-19), 10-Q (filing date: 2016-07-20), 10-Q (filing date: 2016-04-19), 10-K (filing date: 2016-02-02), 10-Q (filing date: 2015-10-21), 10-Q (filing date: 2015-07-22), 10-Q (filing date: 2015-04-22).

1 Q2 2020 Calculation
Net profit margin = 100 × (Net income attributable to Intuitive Surgical, Inc.Q2 2020 + Net income attributable to Intuitive Surgical, Inc.Q1 2020 + Net income attributable to Intuitive Surgical, Inc.Q4 2019 + Net income attributable to Intuitive Surgical, Inc.Q3 2019) ÷ (RevenueQ2 2020 + RevenueQ1 2020 + RevenueQ4 2019 + RevenueQ3 2019)
= 100 × (68,000 + 313,500 + 357,700 + 396,800) ÷ (852,100 + 1,099,500 + 1,277,700 + 1,128,200) = 26.07%

2 Click competitor name to see calculations.

Profitability ratio Description The company
Net profit margin An indicator of profitability, calculated as net income divided by revenue. Intuitive Surgical Inc.’s net profit margin ratio deteriorated from Q4 2019 to Q1 2020 and from Q1 2020 to Q2 2020.

Return on Equity (ROE)

Intuitive Surgical Inc., ROE calculation (quarterly data)

Microsoft Excel LibreOffice Calc
Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selected Financial Data (US$ in thousands)
Net income attributable to Intuitive Surgical, Inc. 68,000  313,500  357,700  396,800  318,300  306,500  292,500  292,500  255,300  287,600  (38,800) 297,500  221,500  179,800  204,000  211,000  184,500  136,400  190,000  167,300  134,500  97,000 
Total Intuitive Surgical, Inc. stockholders’ equity 8,740,500  8,506,700  8,263,800  7,761,400  7,265,300  7,024,200  6,678,800  6,280,600  5,860,600  5,497,100  4,725,200  4,957,900  4,522,300  4,127,500  5,777,800  5,541,800  5,181,500  4,750,400  4,319,500  4,115,200  3,792,700  3,585,400 
Profitability Ratio
ROE1 13.00% 16.30% 16.69% 16.93% 16.65% 16.33% 16.89% 12.68% 13.68% 13.97% 13.97% 18.21% 18.05% 18.88% 12.74% 13.03% 13.09% 13.22% 13.63%
Benchmarks
ROE, Competitors2
Becton, Dickinson & Co. 5.13% 4.30% 5.85% 4.35% 5.06% 4.89% 1.48% 3.61% 0.22% 1.89% 8.50% 6.30% 16.51% 17.26% 12.79% 14.17% 10.57% 9.53% 9.70% 11.24% 15.07% 22.69%
Boston Scientific Corp. 25.53% 31.06% 33.87% 11.24% 14.81% 19.46% 19.15% 8.08% 6.73% 1.59% 1.48% 11.11% 10.89% 6.17% 5.15% 1.25% -5.55% -0.56% -3.78%
Danaher Corp. 9.56% 10.53% 9.94% 7.63% 7.69% 7.66% 9.40% 9.98% 9.81% 9.39% 9.45% 9.39% 8.95% 9.68% 11.10% 10.76% 14.00% 14.47% 14.17%
Medtronic PLC 9.23% 8.78% 9.25% 9.87% 4.56% 6.30% 6.12% 5.59% 9.75% 8.12% 8.01% 8.03% 8.45% 7.18% 6.80% 4.79% 4.43% 4.97% 5.03%
Stryker Corp. 12.55% 16.50% 16.26% 27.82% 29.72% 30.12% 30.29% 12.54% 11.42% 11.06% 10.23% 17.06% 16.94% 17.41% 17.25% 17.78% 17.64% 18.36% 16.91%
Thermo Fisher Scientific Inc. 12.41% 12.85% 12.45% 12.24% 12.33% 11.46% 10.65% 9.55% 9.05% 8.62% 8.76% 9.42% 10.12% 9.96% 9.39% 9.21% 9.39% 9.52% 9.25%
UnitedHealth Group Inc. 26.87% 24.14% 24.02% 24.25% 24.46% 24.39% 23.19% 25.12% 24.56% 23.60% 22.10% 19.04% 18.79% 18.08% 18.33% 17.40% 16.98% 17.09% 17.18%

Based on: 10-Q (filing date: 2020-07-23), 10-Q (filing date: 2020-04-17), 10-K (filing date: 2020-02-07), 10-Q (filing date: 2019-10-18), 10-Q (filing date: 2019-07-22), 10-Q (filing date: 2019-04-19), 10-K (filing date: 2019-02-04), 10-Q (filing date: 2018-10-22), 10-Q (filing date: 2018-07-20), 10-Q (filing date: 2018-04-18), 10-K (filing date: 2018-02-02), 10-Q (filing date: 2017-10-20), 10-Q (filing date: 2017-07-21), 10-Q (filing date: 2017-04-19), 10-K (filing date: 2017-02-06), 10-Q (filing date: 2016-10-19), 10-Q (filing date: 2016-07-20), 10-Q (filing date: 2016-04-19), 10-K (filing date: 2016-02-02), 10-Q (filing date: 2015-10-21), 10-Q (filing date: 2015-07-22), 10-Q (filing date: 2015-04-22).

1 Q2 2020 Calculation
ROE = 100 × (Net income attributable to Intuitive Surgical, Inc.Q2 2020 + Net income attributable to Intuitive Surgical, Inc.Q1 2020 + Net income attributable to Intuitive Surgical, Inc.Q4 2019 + Net income attributable to Intuitive Surgical, Inc.Q3 2019) ÷ Total Intuitive Surgical, Inc. stockholders’ equity
= 100 × (68,000 + 313,500 + 357,700 + 396,800) ÷ 8,740,500 = 13.00%

2 Click competitor name to see calculations.

Profitability ratio Description The company
ROE A profitability ratio calculated as net income divided by shareholders’ equity. Intuitive Surgical Inc.’s ROE deteriorated from Q4 2019 to Q1 2020 and from Q1 2020 to Q2 2020.

Return on Assets (ROA)

Intuitive Surgical Inc., ROA calculation (quarterly data)

Microsoft Excel LibreOffice Calc
Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selected Financial Data (US$ in thousands)
Net income attributable to Intuitive Surgical, Inc. 68,000  313,500  357,700  396,800  318,300  306,500  292,500  292,500  255,300  287,600  (38,800) 297,500  221,500  179,800  204,000  211,000  184,500  136,400  190,000  167,300  134,500  97,000 
Total assets 10,103,600  9,891,100  9,733,200  9,131,300  8,531,600  8,234,900  7,846,700  7,318,600  6,849,600  6,426,200  5,758,000  5,644,600  5,250,800  4,808,000  6,486,900  6,174,700  5,780,800  5,306,300  4,907,300  4,682,300  4,354,500  4,126,200 
Profitability Ratio
ROA1 11.24% 14.02% 14.17% 14.39% 14.18% 13.93% 14.37% 10.88% 11.70% 11.95% 11.46% 15.99% 15.55% 16.21% 11.34% 11.69% 11.73% 11.84% 12.00%
Benchmarks
ROA, Competitors2
Becton, Dickinson & Co. 2.01% 1.76% 2.38% 1.79% 2.05% 1.98% 0.58% 1.43% 0.08% 0.73% 2.92% 2.13% 5.45% 5.38% 3.81% 4.37% 3.09% 2.64% 2.59% 3.01% 3.81% 6.22%
Boston Scientific Corp. 12.93% 14.24% 15.38% 4.07% 5.74% 7.55% 7.96% 3.29% 2.66% 0.58% 0.55% 4.52% 4.29% 2.42% 1.92% 0.46% -1.93% -0.20% -1.32%
Danaher Corp. 4.86% 4.74% 4.85% 4.03% 4.64% 4.67% 5.54% 5.79% 5.55% 5.41% 5.34% 5.20% 4.82% 5.09% 5.64% 6.04% 6.81% 7.33% 6.96%
Medtronic PLC 5.13% 4.84% 5.16% 5.54% 2.56% 3.53% 3.40% 2.93% 5.31% 4.10% 4.04% 4.07% 4.31% 3.70% 3.55% 2.37% 2.21% 2.51% 2.51%
Stryker Corp. 5.09% 7.35% 6.90% 12.85% 13.47% 13.58% 13.05% 5.60% 5.01% 4.60% 4.60% 8.28% 7.98% 8.23% 8.06% 8.22% 7.82% 8.22% 8.86%
Thermo Fisher Scientific Inc. 6.02% 6.25% 6.33% 6.33% 6.11% 5.71% 5.22% 4.66% 4.32% 3.98% 3.93% 4.16% 4.87% 4.70% 4.40% 4.16% 4.73% 4.64% 4.83%
UnitedHealth Group Inc. 8.88% 7.27% 7.96% 7.68% 7.77% 7.83% 7.87% 8.32% 7.67% 7.21% 7.59% 6.14% 5.87% 5.53% 5.71% 5.30% 5.17% 5.10% 5.22%

Based on: 10-Q (filing date: 2020-07-23), 10-Q (filing date: 2020-04-17), 10-K (filing date: 2020-02-07), 10-Q (filing date: 2019-10-18), 10-Q (filing date: 2019-07-22), 10-Q (filing date: 2019-04-19), 10-K (filing date: 2019-02-04), 10-Q (filing date: 2018-10-22), 10-Q (filing date: 2018-07-20), 10-Q (filing date: 2018-04-18), 10-K (filing date: 2018-02-02), 10-Q (filing date: 2017-10-20), 10-Q (filing date: 2017-07-21), 10-Q (filing date: 2017-04-19), 10-K (filing date: 2017-02-06), 10-Q (filing date: 2016-10-19), 10-Q (filing date: 2016-07-20), 10-Q (filing date: 2016-04-19), 10-K (filing date: 2016-02-02), 10-Q (filing date: 2015-10-21), 10-Q (filing date: 2015-07-22), 10-Q (filing date: 2015-04-22).

1 Q2 2020 Calculation
ROA = 100 × (Net income attributable to Intuitive Surgical, Inc.Q2 2020 + Net income attributable to Intuitive Surgical, Inc.Q1 2020 + Net income attributable to Intuitive Surgical, Inc.Q4 2019 + Net income attributable to Intuitive Surgical, Inc.Q3 2019) ÷ Total assets
= 100 × (68,000 + 313,500 + 357,700 + 396,800) ÷ 10,103,600 = 11.24%

2 Click competitor name to see calculations.

Profitability ratio Description The company
ROA A profitability ratio calculated as net income divided by total assets. Intuitive Surgical Inc.’s ROA deteriorated from Q4 2019 to Q1 2020 and from Q1 2020 to Q2 2020.